Steven Rosenberg
MD, PhD
Chief of Surgery
👥Biography 个人简介
Steven Rosenberg pioneered high dose IL-2 as the first immunotherapy to produce durable remissions in metastatic melanoma and renal cell carcinoma. He subsequently developed tumor infiltrating lymphocyte therapy and neoantigen targeted adoptive cell transfer. He remains the central figure in cancer cell based immunotherapy at the NCI.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Steven Rosenberg 的研究动态
Follow Steven Rosenberg's research updates
留下邮箱，当我们发布与 Steven Rosenberg（National Cancer Institute, NIH）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment